Comparison of health state utility estimates from instrument-based and vignette-based methods: a case study in kidney disease

BMC Research Notes

Vasily Belozeroff¹  David Feeny²  Andrew H. Briggs³ 

[1] Amgen Inc.;Department of Economics, McMaster University;William R Lindsay Chair of Health Economics, Health Economics and Technology Assessment, Institute of Health & Wellbeing, University of Glasgow;

关键词: Health-related quality of life;    Quality adjusted life years (QALYs);    Cost-effectiveness;    Medical technology;    Health technology assessment (HTA);   

DOI  :  10.1186/s13104-019-4413-y

来源: DOAJ

【 摘 要 】

Abstract Objective We take advantage of a rare occurrence when two different studies report on the estimation of quality of life utilities for the same health states to assess convergence of the reported measures. Health state utilities are important inputs into health economic models that estimate the impact of new medical technologies using a common metric of health gain—the quality adjusted life-year. Results We find low concordance between the two measures which is concerning in that this could have important ramifications for health care decision making based on estimated cost-effectiveness. We explore possible reasons for the discrepancy between the two measures and draw implications for the design of future studies.

【 授权许可】

Unknown